Borst, Jannie
Ahrends, Tomasz
Bąbała, Nikolina
Melief, Cornelis J. M.
Kastenmüller, Wolfgang
Article History
First Online: 29 July 2018
Competing interests
: J.B. is an inventor on a patent for CD27 agonist antibodies. C.J.M.M. is beneficiary of a management participation plan in ISA Pharmaceuticals, Leiden, Netherlands, is a named inventor on a patent for the use of synthetic long peptides as vaccines and is employed as Chief Scientific Officer by ISA Pharmaceuticals, which exploits this patent. The other authors declare no competing interests.